Back to all News & Events >
Our News
Attitudes and intentions to receive medical and surgical abortions among women seeking pregnancy termination
Principal Investigator: Dr. Brian Fitzsimmons Primary Contact: Nicole Prestley, Research Manager, 604-875-2424 ext 4956, Nicole.Prestley@cw.bc.ca About the study: Health Canada has recently approved Mifegymiso, a medication which is used around the world for medical termination of pregnancy. In order to understand how the use of this medication will impact Canadian women, WHRI is leading a study […]
WHRI Award Winners: UBC Department of OBGYN Academic Day
Congratulations to the WHRI’s Elizabeth McClymont and Dr. Chelsea Elwood for being awarded best Graduate Student and Best Fellow presentations at last Wednesday’s UBC Department of OBGYN Academic Day. Elizabeth McClymont, a Master’s student in Reproductive Sciences working with supervisor Dr. Deborah Money, received the Best Graduate Student award for her presentation, “Two-Year Efficacy of the […]
International Women’s Day Event #BeBoldForChange
Last Wednesday, March 8th, the Women’s Health Research Institute hosted an event to celebrate International Women’s Day. This free event was open to the public with presentations from a panel of experts in women’s health who shared the latest recommendations for a variety of health topics. Events such as these are crucial in empowering women […]
New WHRI Grant Facilitation Services
The WHRI is excited to announce that we have partnered with the Research and Technology Development Office (RTDO) at the BC Children’s Hospital Research Institute to now offer grant facilitation support to WHRI members. Our new grant facilitator, Amber Hui, has a Masters degree in Social and Personality Psychology from the City University of New […]
BC population-based study examines the link between diabetes medications and the risk of endometrial cancer
It is well recognized that women with type 2 diabetes have an increased risk of endometrial (uterine) cancer. There are various pharmacotherapy options for diabetes, including metformin and thiazolidinediones, which reduce insulin levels (insulin-sensitizing drugs), and secretagogues, which increase circulating insulin levels. As hyperinsulinemia is recognized as a risk factor for the development of endometrial […]
Dr. Jan Christilaw appointed as Member to the Order of Canada
We are very pleased to announce that Dr. Jan Christilaw has been appointed to the Order of Canada, which was announced by the Right Honourable David Johnston over the holidays. Dr. Christilaw has spent her career working to improve health outcomes and building capacity of health care providers here in BC, throughout Canada and the […]
CIHR’s new Gender Equity Framework
CIHR has created a new Gender Equity Framework which aims to create an equitable funding system by identifying and eliminating biases towards any individual or group that would hinder access to CIHR funds. 04-1-cihrs-gender-equity-framework_uds
Congratulations to Liz McClymont, Bernard Duval Bursary recipient, Dr. Money and the HPV in HIV Team!
We would like to congratulate Liz McClymont, a master’s student in Reproductive Sciences working with supervisor Dr. Deborah Money, for receiving the Bernard Duval Bursary for first place poster at the 2016 Canadian Immunization Conference, in Ottawa, Ontario. Liz presented data from the “HPV in HIV Study”, reporting on cervical dysplasia and attributable HPV types in […]
WHRI Investigator, Dr. Deborah Money, publishes on the safety of and immune response to the HPV vaccine in HIV positive women
WHRI Investigator Dr. Deborah Money, leading the HPV in HIV Team, published in “Vaccine”! The team reports on their national study of the HPV vaccine in women living with HIV. The HPV vaccine was well-tolerated with promising indicators of effectiveness in preventing HPV infection and associated cervical cancer in women living with HIV. http://authors.elsevier.com/sd/article/S0264410X16306739